nodes	percent_of_prediction	percent_of_DWPC	metapath
Prazosin—ABCG2—Leflunomide—systemic scleroderma	0.211	0.331	CbGbCtD
Prazosin—ABCG2—Mycophenolate mofetil—systemic scleroderma	0.13	0.205	CbGbCtD
Prazosin—ABCB1—Lisinopril—systemic scleroderma	0.0798	0.125	CbGbCtD
Prazosin—ABCB1—Captopril—systemic scleroderma	0.0598	0.0938	CbGbCtD
Prazosin—ABCG2—Methotrexate—systemic scleroderma	0.0523	0.0821	CbGbCtD
Prazosin—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.047	0.0738	CbGbCtD
Prazosin—ABCB1—Prednisone—systemic scleroderma	0.0376	0.059	CbGbCtD
Prazosin—ABCB1—Methotrexate—systemic scleroderma	0.0189	0.0296	CbGbCtD
Prazosin—Body temperature increased—Mometasone—systemic scleroderma	0.000953	0.00263	CcSEcCtD
Prazosin—Discomfort—Azathioprine—systemic scleroderma	0.000953	0.00263	CcSEcCtD
Prazosin—Paraesthesia—Captopril—systemic scleroderma	0.000951	0.00262	CcSEcCtD
Prazosin—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.000947	0.00261	CcSEcCtD
Prazosin—Palpitations—Leflunomide—systemic scleroderma	0.000945	0.00261	CcSEcCtD
Prazosin—Dyspnoea—Captopril—systemic scleroderma	0.000944	0.0026	CcSEcCtD
Prazosin—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.000942	0.0026	CcSEcCtD
Prazosin—Somnolence—Captopril—systemic scleroderma	0.000942	0.0026	CcSEcCtD
Prazosin—Gynaecomastia—Methotrexate—systemic scleroderma	0.000934	0.00257	CcSEcCtD
Prazosin—Alopecia—Lisinopril—systemic scleroderma	0.000933	0.00257	CcSEcCtD
Prazosin—Dizziness—Pentoxifylline—systemic scleroderma	0.000924	0.00255	CcSEcCtD
Prazosin—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.000921	0.00254	CcSEcCtD
Prazosin—Malaise—Mycophenolic acid—systemic scleroderma	0.00092	0.00254	CcSEcCtD
Prazosin—Vertigo—Mycophenolic acid—systemic scleroderma	0.000917	0.00253	CcSEcCtD
Prazosin—Syncope—Mycophenolic acid—systemic scleroderma	0.000915	0.00252	CcSEcCtD
Prazosin—Fatigue—Captopril—systemic scleroderma	0.000913	0.00252	CcSEcCtD
Prazosin—Arthralgia—Leflunomide—systemic scleroderma	0.000911	0.00251	CcSEcCtD
Prazosin—Constipation—Captopril—systemic scleroderma	0.000906	0.0025	CcSEcCtD
Prazosin—Tension—Lisinopril—systemic scleroderma	0.000902	0.00249	CcSEcCtD
Prazosin—Palpitations—Mycophenolic acid—systemic scleroderma	0.000902	0.00249	CcSEcCtD
Prazosin—Discomfort—Leflunomide—systemic scleroderma	0.0009	0.00248	CcSEcCtD
Prazosin—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.000897	0.00247	CcSEcCtD
Prazosin—Nervousness—Lisinopril—systemic scleroderma	0.000893	0.00246	CcSEcCtD
Prazosin—Dry mouth—Leflunomide—systemic scleroderma	0.000891	0.00245	CcSEcCtD
Prazosin—Vomiting—Pentoxifylline—systemic scleroderma	0.000889	0.00245	CcSEcCtD
Prazosin—Rash—Pentoxifylline—systemic scleroderma	0.000881	0.00243	CcSEcCtD
Prazosin—Dermatitis—Pentoxifylline—systemic scleroderma	0.000881	0.00243	CcSEcCtD
Prazosin—Headache—Pentoxifylline—systemic scleroderma	0.000876	0.00241	CcSEcCtD
Prazosin—Feeling abnormal—Captopril—systemic scleroderma	0.000873	0.00241	CcSEcCtD
Prazosin—Arthralgia—Mycophenolic acid—systemic scleroderma	0.000869	0.00239	CcSEcCtD
Prazosin—Vision blurred—Lisinopril—systemic scleroderma	0.000866	0.00239	CcSEcCtD
Prazosin—Asthenia—Mometasone—systemic scleroderma	0.000865	0.00238	CcSEcCtD
Prazosin—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.000863	0.00238	CcSEcCtD
Prazosin—Discomfort—Mycophenolic acid—systemic scleroderma	0.000858	0.00237	CcSEcCtD
Prazosin—Pruritus—Mometasone—systemic scleroderma	0.000853	0.00235	CcSEcCtD
Prazosin—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000853	0.00235	CcSEcCtD
Prazosin—Tachycardia—Leflunomide—systemic scleroderma	0.000852	0.00235	CcSEcCtD
Prazosin—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00085	0.00234	CcSEcCtD
Prazosin—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000844	0.00233	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000842	0.00232	CcSEcCtD
Prazosin—Body temperature increased—Captopril—systemic scleroderma	0.000837	0.00231	CcSEcCtD
Prazosin—Oedema—Mycophenolic acid—systemic scleroderma	0.000833	0.0023	CcSEcCtD
Prazosin—Nausea—Pentoxifylline—systemic scleroderma	0.00083	0.00229	CcSEcCtD
Prazosin—Malaise—Lisinopril—systemic scleroderma	0.000829	0.00228	CcSEcCtD
Prazosin—Vertigo—Lisinopril—systemic scleroderma	0.000826	0.00228	CcSEcCtD
Prazosin—Diarrhoea—Mometasone—systemic scleroderma	0.000825	0.00227	CcSEcCtD
Prazosin—Syncope—Lisinopril—systemic scleroderma	0.000824	0.00227	CcSEcCtD
Prazosin—Shock—Mycophenolic acid—systemic scleroderma	0.000819	0.00226	CcSEcCtD
Prazosin—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000818	0.00225	CcSEcCtD
Prazosin—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000813	0.00224	CcSEcCtD
Prazosin—Palpitations—Lisinopril—systemic scleroderma	0.000812	0.00224	CcSEcCtD
Prazosin—Loss of consciousness—Lisinopril—systemic scleroderma	0.000808	0.00223	CcSEcCtD
Prazosin—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000805	0.00222	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000795	0.00219	CcSEcCtD
Prazosin—Tension—Mycophenolate mofetil—systemic scleroderma	0.00079	0.00218	CcSEcCtD
Prazosin—Insomnia—Leflunomide—systemic scleroderma	0.00079	0.00218	CcSEcCtD
Prazosin—Paraesthesia—Leflunomide—systemic scleroderma	0.000784	0.00216	CcSEcCtD
Prazosin—Arthralgia—Lisinopril—systemic scleroderma	0.000783	0.00216	CcSEcCtD
Prazosin—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000782	0.00216	CcSEcCtD
Prazosin—Dyspnoea—Leflunomide—systemic scleroderma	0.000778	0.00214	CcSEcCtD
Prazosin—Discomfort—Lisinopril—systemic scleroderma	0.000773	0.00213	CcSEcCtD
Prazosin—Pancreatitis—Prednisone—systemic scleroderma	0.000768	0.00212	CcSEcCtD
Prazosin—Vomiting—Mometasone—systemic scleroderma	0.000767	0.00211	CcSEcCtD
Prazosin—Dry mouth—Lisinopril—systemic scleroderma	0.000765	0.00211	CcSEcCtD
Prazosin—Sweating increased—Prednisone—systemic scleroderma	0.000763	0.0021	CcSEcCtD
Prazosin—Feeling abnormal—Azathioprine—systemic scleroderma	0.000762	0.0021	CcSEcCtD
Prazosin—Rash—Mometasone—systemic scleroderma	0.00076	0.0021	CcSEcCtD
Prazosin—Asthenia—Captopril—systemic scleroderma	0.00076	0.00209	CcSEcCtD
Prazosin—Dermatitis—Mometasone—systemic scleroderma	0.00076	0.00209	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000759	0.00209	CcSEcCtD
Prazosin—Headache—Mometasone—systemic scleroderma	0.000756	0.00208	CcSEcCtD
Prazosin—Insomnia—Mycophenolic acid—systemic scleroderma	0.000753	0.00208	CcSEcCtD
Prazosin—Fatigue—Leflunomide—systemic scleroderma	0.000753	0.00207	CcSEcCtD
Prazosin—Oedema—Lisinopril—systemic scleroderma	0.00075	0.00207	CcSEcCtD
Prazosin—Pruritus—Captopril—systemic scleroderma	0.000749	0.00207	CcSEcCtD
Prazosin—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000748	0.00206	CcSEcCtD
Prazosin—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000747	0.00206	CcSEcCtD
Prazosin—Pain—Leflunomide—systemic scleroderma	0.000747	0.00206	CcSEcCtD
Prazosin—Constipation—Leflunomide—systemic scleroderma	0.000747	0.00206	CcSEcCtD
Prazosin—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000743	0.00205	CcSEcCtD
Prazosin—Somnolence—Mycophenolic acid—systemic scleroderma	0.00074	0.00204	CcSEcCtD
Prazosin—Shock—Lisinopril—systemic scleroderma	0.000738	0.00203	CcSEcCtD
Prazosin—Tachycardia—Lisinopril—systemic scleroderma	0.000732	0.00202	CcSEcCtD
Prazosin—Body temperature increased—Azathioprine—systemic scleroderma	0.000731	0.00201	CcSEcCtD
Prazosin—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000726	0.002	CcSEcCtD
Prazosin—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000725	0.002	CcSEcCtD
Prazosin—Diarrhoea—Captopril—systemic scleroderma	0.000725	0.002	CcSEcCtD
Prazosin—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000724	0.00199	CcSEcCtD
Prazosin—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000722	0.00199	CcSEcCtD
Prazosin—Erectile dysfunction—Prednisone—systemic scleroderma	0.000722	0.00199	CcSEcCtD
Prazosin—Feeling abnormal—Leflunomide—systemic scleroderma	0.000719	0.00198	CcSEcCtD
Prazosin—Fatigue—Mycophenolic acid—systemic scleroderma	0.000718	0.00198	CcSEcCtD
Prazosin—Nausea—Mometasone—systemic scleroderma	0.000716	0.00197	CcSEcCtD
Prazosin—Pain—Mycophenolic acid—systemic scleroderma	0.000712	0.00196	CcSEcCtD
Prazosin—Constipation—Mycophenolic acid—systemic scleroderma	0.000712	0.00196	CcSEcCtD
Prazosin—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000712	0.00196	CcSEcCtD
Prazosin—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000708	0.00195	CcSEcCtD
Prazosin—Dizziness—Captopril—systemic scleroderma	0.000701	0.00193	CcSEcCtD
Prazosin—Urticaria—Leflunomide—systemic scleroderma	0.000694	0.00191	CcSEcCtD
Prazosin—Body temperature increased—Leflunomide—systemic scleroderma	0.00069	0.0019	CcSEcCtD
Prazosin—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000686	0.00189	CcSEcCtD
Prazosin—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000686	0.00189	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000684	0.00188	CcSEcCtD
Prazosin—Hypersensitivity—Azathioprine—systemic scleroderma	0.000681	0.00188	CcSEcCtD
Prazosin—Insomnia—Lisinopril—systemic scleroderma	0.000679	0.00187	CcSEcCtD
Prazosin—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000677	0.00187	CcSEcCtD
Prazosin—Paraesthesia—Lisinopril—systemic scleroderma	0.000674	0.00186	CcSEcCtD
Prazosin—Vomiting—Captopril—systemic scleroderma	0.000674	0.00186	CcSEcCtD
Prazosin—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000671	0.00185	CcSEcCtD
Prazosin—Dyspnoea—Lisinopril—systemic scleroderma	0.000669	0.00184	CcSEcCtD
Prazosin—Rash—Captopril—systemic scleroderma	0.000668	0.00184	CcSEcCtD
Prazosin—Dermatitis—Captopril—systemic scleroderma	0.000667	0.00184	CcSEcCtD
Prazosin—Somnolence—Lisinopril—systemic scleroderma	0.000667	0.00184	CcSEcCtD
Prazosin—Headache—Captopril—systemic scleroderma	0.000664	0.00183	CcSEcCtD
Prazosin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000658	0.00181	CcSEcCtD
Prazosin—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000657	0.00181	CcSEcCtD
Prazosin—Fatigue—Lisinopril—systemic scleroderma	0.000647	0.00178	CcSEcCtD
Prazosin—Shock—Mycophenolate mofetil—systemic scleroderma	0.000647	0.00178	CcSEcCtD
Prazosin—Hypersensitivity—Leflunomide—systemic scleroderma	0.000643	0.00177	CcSEcCtD
Prazosin—Pancreatitis—Methotrexate—systemic scleroderma	0.000642	0.00177	CcSEcCtD
Prazosin—Pain—Lisinopril—systemic scleroderma	0.000642	0.00177	CcSEcCtD
Prazosin—Constipation—Lisinopril—systemic scleroderma	0.000642	0.00177	CcSEcCtD
Prazosin—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000642	0.00177	CcSEcCtD
Prazosin—Bradycardia—Prednisone—systemic scleroderma	0.000638	0.00176	CcSEcCtD
Prazosin—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000635	0.00175	CcSEcCtD
Prazosin—Diarrhoea—Azathioprine—systemic scleroderma	0.000633	0.00174	CcSEcCtD
Prazosin—Nausea—Captopril—systemic scleroderma	0.000629	0.00173	CcSEcCtD
Prazosin—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000628	0.00173	CcSEcCtD
Prazosin—Asthenia—Leflunomide—systemic scleroderma	0.000626	0.00173	CcSEcCtD
Prazosin—Hallucination—Prednisone—systemic scleroderma	0.000624	0.00172	CcSEcCtD
Prazosin—Feeling abnormal—Lisinopril—systemic scleroderma	0.000618	0.0017	CcSEcCtD
Prazosin—Pruritus—Leflunomide—systemic scleroderma	0.000618	0.0017	CcSEcCtD
Prazosin—Dizziness—Azathioprine—systemic scleroderma	0.000611	0.00168	CcSEcCtD
Prazosin—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000603	0.00166	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000599	0.00165	CcSEcCtD
Prazosin—Asthenia—Mycophenolic acid—systemic scleroderma	0.000598	0.00165	CcSEcCtD
Prazosin—Diarrhoea—Leflunomide—systemic scleroderma	0.000597	0.00165	CcSEcCtD
Prazosin—Urticaria—Lisinopril—systemic scleroderma	0.000596	0.00164	CcSEcCtD
Prazosin—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000595	0.00164	CcSEcCtD
Prazosin—Body temperature increased—Lisinopril—systemic scleroderma	0.000593	0.00163	CcSEcCtD
Prazosin—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00059	0.00163	CcSEcCtD
Prazosin—Pruritus—Mycophenolic acid—systemic scleroderma	0.000589	0.00162	CcSEcCtD
Prazosin—Vomiting—Azathioprine—systemic scleroderma	0.000588	0.00162	CcSEcCtD
Prazosin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000586	0.00161	CcSEcCtD
Prazosin—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000584	0.00161	CcSEcCtD
Prazosin—Drowsiness—Methotrexate—systemic scleroderma	0.000584	0.00161	CcSEcCtD
Prazosin—Rash—Azathioprine—systemic scleroderma	0.000583	0.00161	CcSEcCtD
Prazosin—Dermatitis—Azathioprine—systemic scleroderma	0.000582	0.0016	CcSEcCtD
Prazosin—Flushing—Prednisone—systemic scleroderma	0.000582	0.0016	CcSEcCtD
Prazosin—Headache—Azathioprine—systemic scleroderma	0.000579	0.0016	CcSEcCtD
Prazosin—Dizziness—Leflunomide—systemic scleroderma	0.000577	0.00159	CcSEcCtD
Prazosin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00057	0.00157	CcSEcCtD
Prazosin—Pain—Mycophenolate mofetil—systemic scleroderma	0.000562	0.00155	CcSEcCtD
Prazosin—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000562	0.00155	CcSEcCtD
Prazosin—Vomiting—Leflunomide—systemic scleroderma	0.000555	0.00153	CcSEcCtD
Prazosin—Alopecia—Prednisone—systemic scleroderma	0.000554	0.00153	CcSEcCtD
Prazosin—Hypersensitivity—Lisinopril—systemic scleroderma	0.000553	0.00152	CcSEcCtD
Prazosin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000551	0.00152	CcSEcCtD
Prazosin—Epistaxis—Methotrexate—systemic scleroderma	0.000551	0.00152	CcSEcCtD
Prazosin—Rash—Leflunomide—systemic scleroderma	0.000551	0.00152	CcSEcCtD
Prazosin—Dermatitis—Leflunomide—systemic scleroderma	0.00055	0.00152	CcSEcCtD
Prazosin—Nausea—Azathioprine—systemic scleroderma	0.000549	0.00151	CcSEcCtD
Prazosin—Headache—Leflunomide—systemic scleroderma	0.000547	0.00151	CcSEcCtD
Prazosin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000542	0.00149	CcSEcCtD
Prazosin—Asthenia—Lisinopril—systemic scleroderma	0.000538	0.00148	CcSEcCtD
Prazosin—Pruritus—Lisinopril—systemic scleroderma	0.000531	0.00146	CcSEcCtD
Prazosin—Vomiting—Mycophenolic acid—systemic scleroderma	0.00053	0.00146	CcSEcCtD
Prazosin—Rash—Mycophenolic acid—systemic scleroderma	0.000525	0.00145	CcSEcCtD
Prazosin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000525	0.00145	CcSEcCtD
Prazosin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000522	0.00144	CcSEcCtD
Prazosin—Headache—Mycophenolic acid—systemic scleroderma	0.000522	0.00144	CcSEcCtD
Prazosin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00052	0.00143	CcSEcCtD
Prazosin—Nausea—Leflunomide—systemic scleroderma	0.000519	0.00143	CcSEcCtD
Prazosin—Vision blurred—Prednisone—systemic scleroderma	0.000515	0.00142	CcSEcCtD
Prazosin—Diarrhoea—Lisinopril—systemic scleroderma	0.000513	0.00141	CcSEcCtD
Prazosin—Ill-defined disorder—Prednisone—systemic scleroderma	0.000507	0.0014	CcSEcCtD
Prazosin—Dizziness—Lisinopril—systemic scleroderma	0.000496	0.00137	CcSEcCtD
Prazosin—Nausea—Mycophenolic acid—systemic scleroderma	0.000495	0.00136	CcSEcCtD
Prazosin—Malaise—Prednisone—systemic scleroderma	0.000492	0.00136	CcSEcCtD
Prazosin—Vertigo—Prednisone—systemic scleroderma	0.000491	0.00135	CcSEcCtD
Prazosin—Syncope—Prednisone—systemic scleroderma	0.00049	0.00135	CcSEcCtD
Prazosin—Tinnitus—Methotrexate—systemic scleroderma	0.000489	0.00135	CcSEcCtD
Prazosin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000484	0.00133	CcSEcCtD
Prazosin—Loss of consciousness—Prednisone—systemic scleroderma	0.00048	0.00132	CcSEcCtD
Prazosin—Vomiting—Lisinopril—systemic scleroderma	0.000477	0.00131	CcSEcCtD
Prazosin—Rash—Lisinopril—systemic scleroderma	0.000473	0.0013	CcSEcCtD
Prazosin—Dermatitis—Lisinopril—systemic scleroderma	0.000473	0.0013	CcSEcCtD
Prazosin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000472	0.0013	CcSEcCtD
Prazosin—Headache—Lisinopril—systemic scleroderma	0.00047	0.0013	CcSEcCtD
Prazosin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000465	0.00128	CcSEcCtD
Prazosin—Arthralgia—Prednisone—systemic scleroderma	0.000465	0.00128	CcSEcCtD
Prazosin—Alopecia—Methotrexate—systemic scleroderma	0.000463	0.00128	CcSEcCtD
Prazosin—Discomfort—Prednisone—systemic scleroderma	0.000459	0.00127	CcSEcCtD
Prazosin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00045	0.00124	CcSEcCtD
Prazosin—Nausea—Lisinopril—systemic scleroderma	0.000446	0.00123	CcSEcCtD
Prazosin—Oedema—Prednisone—systemic scleroderma	0.000446	0.00123	CcSEcCtD
Prazosin—Shock—Prednisone—systemic scleroderma	0.000438	0.00121	CcSEcCtD
Prazosin—Tachycardia—Prednisone—systemic scleroderma	0.000435	0.0012	CcSEcCtD
Prazosin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000435	0.0012	CcSEcCtD
Prazosin—Hyperhidrosis—Prednisone—systemic scleroderma	0.000431	0.00119	CcSEcCtD
Prazosin—Vision blurred—Methotrexate—systemic scleroderma	0.00043	0.00118	CcSEcCtD
Prazosin—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000423	0.00117	CcSEcCtD
Prazosin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000418	0.00115	CcSEcCtD
Prazosin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000414	0.00114	CcSEcCtD
Prazosin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000414	0.00114	CcSEcCtD
Prazosin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000412	0.00113	CcSEcCtD
Prazosin—Malaise—Methotrexate—systemic scleroderma	0.000411	0.00113	CcSEcCtD
Prazosin—Vertigo—Methotrexate—systemic scleroderma	0.00041	0.00113	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000406	0.00112	CcSEcCtD
Prazosin—Insomnia—Prednisone—systemic scleroderma	0.000403	0.00111	CcSEcCtD
Prazosin—Paraesthesia—Prednisone—systemic scleroderma	0.0004	0.0011	CcSEcCtD
Prazosin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00039	0.00108	CcSEcCtD
Prazosin—Arthralgia—Methotrexate—systemic scleroderma	0.000388	0.00107	CcSEcCtD
Prazosin—Fatigue—Prednisone—systemic scleroderma	0.000384	0.00106	CcSEcCtD
Prazosin—Discomfort—Methotrexate—systemic scleroderma	0.000384	0.00106	CcSEcCtD
Prazosin—Constipation—Prednisone—systemic scleroderma	0.000381	0.00105	CcSEcCtD
Prazosin—Feeling abnormal—Prednisone—systemic scleroderma	0.000367	0.00101	CcSEcCtD
Prazosin—Hyperhidrosis—Methotrexate—systemic scleroderma	0.00036	0.000992	CcSEcCtD
Prazosin—Urticaria—Prednisone—systemic scleroderma	0.000354	0.000975	CcSEcCtD
Prazosin—Body temperature increased—Prednisone—systemic scleroderma	0.000352	0.000971	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000339	0.000935	CcSEcCtD
Prazosin—Insomnia—Methotrexate—systemic scleroderma	0.000337	0.000928	CcSEcCtD
Prazosin—Paraesthesia—Methotrexate—systemic scleroderma	0.000334	0.000921	CcSEcCtD
Prazosin—Dyspnoea—Methotrexate—systemic scleroderma	0.000332	0.000915	CcSEcCtD
Prazosin—Somnolence—Methotrexate—systemic scleroderma	0.000331	0.000912	CcSEcCtD
Prazosin—Hypersensitivity—Prednisone—systemic scleroderma	0.000328	0.000905	CcSEcCtD
Prazosin—Fatigue—Methotrexate—systemic scleroderma	0.000321	0.000885	CcSEcCtD
Prazosin—Asthenia—Prednisone—systemic scleroderma	0.00032	0.000881	CcSEcCtD
Prazosin—Pain—Methotrexate—systemic scleroderma	0.000318	0.000877	CcSEcCtD
Prazosin—Pruritus—Prednisone—systemic scleroderma	0.000315	0.000869	CcSEcCtD
Prazosin—Feeling abnormal—Methotrexate—systemic scleroderma	0.000307	0.000846	CcSEcCtD
Prazosin—Diarrhoea—Prednisone—systemic scleroderma	0.000305	0.00084	CcSEcCtD
Prazosin—Urticaria—Methotrexate—systemic scleroderma	0.000296	0.000815	CcSEcCtD
Prazosin—Dizziness—Prednisone—systemic scleroderma	0.000295	0.000812	CcSEcCtD
Prazosin—Body temperature increased—Methotrexate—systemic scleroderma	0.000294	0.000811	CcSEcCtD
Prazosin—Vomiting—Prednisone—systemic scleroderma	0.000283	0.000781	CcSEcCtD
Prazosin—Rash—Prednisone—systemic scleroderma	0.000281	0.000774	CcSEcCtD
Prazosin—Dermatitis—Prednisone—systemic scleroderma	0.000281	0.000773	CcSEcCtD
Prazosin—Headache—Prednisone—systemic scleroderma	0.000279	0.000769	CcSEcCtD
Prazosin—Hypersensitivity—Methotrexate—systemic scleroderma	0.000274	0.000756	CcSEcCtD
Prazosin—Asthenia—Methotrexate—systemic scleroderma	0.000267	0.000736	CcSEcCtD
Prazosin—Nausea—Prednisone—systemic scleroderma	0.000265	0.000729	CcSEcCtD
Prazosin—Pruritus—Methotrexate—systemic scleroderma	0.000263	0.000726	CcSEcCtD
Prazosin—Diarrhoea—Methotrexate—systemic scleroderma	0.000255	0.000702	CcSEcCtD
Prazosin—Dizziness—Methotrexate—systemic scleroderma	0.000246	0.000679	CcSEcCtD
Prazosin—Vomiting—Methotrexate—systemic scleroderma	0.000237	0.000652	CcSEcCtD
Prazosin—Rash—Methotrexate—systemic scleroderma	0.000235	0.000647	CcSEcCtD
Prazosin—Dermatitis—Methotrexate—systemic scleroderma	0.000235	0.000646	CcSEcCtD
Prazosin—Headache—Methotrexate—systemic scleroderma	0.000233	0.000643	CcSEcCtD
Prazosin—Nausea—Methotrexate—systemic scleroderma	0.000221	0.00061	CcSEcCtD
